Enter your login e-mail to the account
Search
Search parameters
Search results
- Individual approach choosing appropriate therapy for patient with multiple sclerosis
prof. MUDr. Ľubomír Lisý, DrSc.
(5/2016, Interdisciplinary consilium ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(2/2017, Interdisciplinary consilium ) - Multiple sclerosis and motherhood The article deals with the relationship of multiple
MUDr. Viera Hančinová
(1/2013, Interdisciplinary consilium ) - Is concern about vaccination in patients with multiple sclerosis reasonable?
MUDr. Iveta Lisá, PhD.
(2/2016, Interdisciplinary consilium ) - Possibilities for early detection of patients with the diagnosis of MS in general practitioner
prof. MUDr. Egon Kurča, PhD., MUDr. Natália Jankovičová,
(3/2016, Interdisciplinary consilium ) - The diagnosis and treatment of multiple sclerosis
doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(4/2015, Interdisciplinary consilium )
- New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - Safety monitoring of escalation treatment of multiple sclerosis
MUDr. Jiří Piťha
(5/2019, Review articles ) - Link atrophy and disability in multiple sclerosis
MUDr. Jiří Piťha
(3/2014, Review articles ) - Cognitive impairment in multiple sclerosis
doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2015, Review articles ) - Role of T and B cells in pathogenesis of multiple sclerosis
prof. RNDr. Jan Krejsek, CSc., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(2/2016, Review articles ) - Hair loss due to treatment of multiple sclerosis
MUDr. Radek Litvik, MUDr. Olga Zapletalová
(2/2017, From the boundary of neurology ) - Smoking and multiple sclerosis
Doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(2/2017, Review articles ) - Woman and multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(6/2014, Main topic ) - The individual preferences in choice of suitable MS treatment therapy
MUDr. Marta Vachová
(6/2014, Review articles ) - Fingolimod in clinical practice: case reports
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(6/2014, Case reports ) - Recent advances in treatment of multiple sclerosis with interferon beta in Czech Republic?
MUDr. Michal Dufek
(1/2011, Review articles ) - Porovnanie bezpečnosti a monitoringu DMD liekov prvej eskalačnej línie – dimetylfumarát, fingolimod, kladribin a okrelizumab
MUDr. Eva Kmeťová
(6/2018, Review articles ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Safety aspects of treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa, MUDr. Stanislav Kopecký
(5/2016, Review articles ) - Fingolimod treatment of multiple sclerosis at any age
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(2/2022, Review articles ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - NEDA-4 concept as a treatment outcome in multiple sclerosis patients
MUDr. Pavel Hradílek, Ph.D.
(3/2016, Review articles ) - Clinical experience with alemtuzumab
MUDr. Eva Meluzínová, MUDr. Jana Libertínová, MUDr. Petra Lišková
(3/2016, Case reports ) - Dimethyl-fumarate in treating relapsing-remitting multiple sclerosis
MUDr. Eva Meluzínová
(4/2014, Review articles ) - Multiple sclerosis and pregnancy
MUDr. Olga Zapletalová
(4/2014, Review articles ) - Magnetic resonance imaging for detection of opportunistic infection of patients with multiple sclerosis
doc. MUDr. Dana Horáková, Ph.D., prof. MUDr. Manuela Vaněčková, Ph.D.
(6/2016, Review articles ) - Escalation therapy in multiple sclerosis
MUDr. Pavel Ryška, Ph.D., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2016, Case reports ) - Multiple sclerosis: dimethyl fumarate and fingolimod – from clinical trials to clinical practice
Doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek, PhD.
(6/2017, Pharmacotherapy ) - Treatment of multiple sclerosis in Czech Republic – options and reality
MUDr. Michal Dufek
(1/2014, Review articles ) - Sphingosine-1-phosphate receptor modulators in the treatment of early phase multiple sclerosis
MUDr. Marek Peterka , MUDr. Pavel Potužník, Ph.D.
(5/2023, Review articles ) - Súčasné možnosti dlhodobej liečby roztrúsenej sklerózy: výhody a nevýhody perorálnej liečby roztrúsenej sklerózy
MUDr. Zuzana Matejčíková, Ph.D.
(3/2018, Review articles ) - Zimné dni sklerózy multiplex, 20. – 21. január 2012, Štrbské Pleso
(1/2012, Abstracts ) - Drug induced hepatopathy after fingolimod treatment
MUDr. Magdaléna Hladíková, Ph.D., MUDr. Petra Praksová, Ph.D.
(4/2015, Case reports ) - Alemtuzumab in multiple sclerosis treatment
MUDr. Eva Meluzínová
(4/2015, Pharmacotherapy ) - Sclerosis multiplex
doc. MUDr. Jarmila Szilasiová, PhD.
(2/2014, Main topic ) - New treatment options for pediatric patients with multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(3/2019, Review articles ) - Primary progressive multiple sclerosis – diagnosis, clinical aspects and treatment
MUDr. Ladislav Gurčík, PhD.
(5/2011, Review articles ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(4/2016, Review articles ) - New ways of administering injection drugs in relapsing multiple sclerosis
MUDr. Jiří Piťha
(5/2015, Review articles ) - The pitfalls of treating rapidly evolving multiple sclerosis
MUDr. Pavel Hok, prof. MUDr. Vojtěch Thon, Ph.D., prof. MUDr. Jan Mareš, Ph.D., MBA
(2/2020, Case reports ) - Does the development of new drugs for multiple sclerosis change the prognosis of the patient?
prof. MUDr. Eva Havrdová, CSc.
(3/2011, Review articles ) - Assessing quality of life of patients with multiple sclerosis
MUDr. Ema Kantorová, PhD, prof. MUDr. Egon Kurča, PhD.,, MUDr. Jozef Michalik
(4/2012, Review articles )
- Cancer drug consumption 2012-2015
Ing. Tomáš Mesároš, MBA, JUDr. Ing. Štefan Mesároš, PhD.
(2/2017, Main topic ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic )
- Cutaneous complications of the 1. line immunomodulators in the Multiple Sclerosis treatment
doc. MUDr. Eleonóra Klímová, CSc., MUDr. Adrián Ryník, MUDr. Monika Daňová, PhDr. Andrea Lengyelová
(1/2013, Interdisciplinary consilium )
- The current therapeutic options for relapsing-remiting form of multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(1/2013, Current pharmacotherapy ) - Nové liečivá v EÚ registrované v roku 2011 (I.)
PharmDr. Peter Stanko
(1/2012, New drugs ) - New therapy options for multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(4/2013, Current pharmacotherapy )